Abstract Introduction: Delayed diagnosis of transthyretin amyloid cardiomyopathy (ATTR-CM) represents a missed opportunity for intervention. This study estimates the health benefits o
Background The newly approved biologics and Janus kinase inhibitors (JAKi) for pediatric atopic dermatitis (AD) offer additional options for clinical treatment. However, the efficacy and safety differ
Regression exploring the linear dependence of the relative reduction in 3-year cumulative incidence in arms A and B compared to arm C (on the linear-scale) on process parameters (see File S1 for detai
